Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001842952-24-000037
Filing Date
2024-05-16
Accepted
2024-05-16 16:01:26
Documents
1
Effectiveness Date
2024-05-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11901
  Complete submission text file 0001842952-24-000037.txt   13212
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-513547 | Film No.: 24955372
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)